Primary Site >> Esophagus Cancer
Gene >> FOXP3
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. PMID: 16328385 Ref: Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma. PMID: 16799337 |
Ref: Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer. PMID: 19307989 Ref: Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer. PMID: 19632080 |
Ref: Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data. PMID: 19788437 |
Ref: Localization of IL-17+Foxp3+ T cells in esophageal cancer. PMID: 21314287 Ref: CD4 + CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy. PMID: 21607687 |
Ref: The immunological impact of neoadjuvant chemotherapy on the tumor microenvironment of esophageal squamous cell carcinoma. PMID: 21822560 Ref: FOXP3 expression in esophageal cancer cells is associated with poor prognosis in esophageal cancer. PMID: 22389297 |
Ref: Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes. PMID: 23436617 Ref: Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma. PMID: 23483489 |
Ref: Study of circulating antibodies against CD25 and FOXP3 in breast cancer. PMID: 24347486 Ref: Perioperative changes in peripheral regulatory B cells of patients with esophageal cancer. PMID: 24969402 Ref: B7-H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer. PMID: 25337246 |
Ref: Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy. PMID: 25469286 Ref: Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy. PMID: 26369701 Ref: Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients. PMID: 26429981 |
Ref: Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cells. PMID: 27057430 Ref: Foxp3+ lymphocyte count in Barrett's esophagus tissue is higher than in in amed esophageal tissue. PMID: 28275271 |
Ref: Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer. PMID: 28084319 Ref: The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma. PMID: 29069772 |
Ref: Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis. PMID: 29414812 Ref: IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer. PMID: 29595533 Ref: Cancer-Associated Fibroblasts Affect Intratumoral CD8(+) and FoxP3(+) T Cells Via IL6 in the Tumor Microenvironment. PMID: 29921731 |